| Volume: | 36,369,405 |
|---|---|
| Day's Low: | $35.33 |
| 52-wk Low: | $31.25 |
| Previous Close: | $35.33 |
| Dividend: | $0.07 |
| Market Cap: | 74,517,300 |
| Avg Volume: | 19,909,300 |
|---|---|
| Day's High: | $36.67 |
| 52-wk High: | $35.72 |
| Open Price: | $35.45 |
| Yield: | 4.30% |
| P/E (Forward): | 10.80 |
| 2:24 PM | 11/19/2009 | Abbott Hesitates To Promote Niaspan Study Due To FDA Rules |
| 2:45 PM | 11/18/2009 | UPDATE: Study Questions Utility Of Merck Cholesterol Drugs |
| 2:38 PM | 11/18/2009 | CORRECT:In Overhaul,Drug Industry Insider Sees 'Good, Bad, Ugly' |
| 11:45 AM | 11/18/2009 | Another Study Questions Utility Of Merck Cholesterol Drugs |
| 5:08 PM | 11/17/2009 | UPDATE: Crestor Cuts Cardiovascular Problems In Women |
| 2:34 PM | 11/17/2009 | Former Schering CEO Becomes Senior Adviser To Warburg Pincus |
| 6:00 PM | 11/16/2009 | Gates Fund Boosts Holdings In Consumer Staples, Waste Handlers |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.90 | 0.80 | 12.50 |
| EPS, GAAP | 0.29 | 0.34 | -14.71 |
| Consensus Estimate | 0.82 | 0.79 | 3.80 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.34 | 3.42 | -2.34 |
| EPS, GAAP | 1.46 | -1.46 | NA |
| Consensus Estimate | 3.11 | NA | NA |
| MRK | Industry Average | |
| P/E (TTM) | 24.20 | 16.80 |
| P/E (Forward) | 10.80 | 1.10 |
| PEG Ratio | 3.32 | 0.07 |
| Price/Sales | 3.51 | 3.05 |
| Beta | 0.86 | 0.82 |